As Verisign (VRSN) Stock Rose, California Public Employees Retirement System Has Boosted Holding by $1.27 Million; Foresite Capital Management Ii Has Upped Holding in Epizyme (EPZM) as Stock Rose

February 18, 2018 - By Peter Erickson

California Public Employees Retirement System increased its stake in Verisign Inc (VRSN) by 4.53% based on its latest 2017Q3 regulatory filing with the SEC. California Public Employees Retirement System bought 11,959 shares as the company’s stock rose 8.37% with the market. The institutional investor held 276,059 shares of the technology company at the end of 2017Q3, valued at $29.37 million, up from 264,100 at the end of the previous reported quarter. California Public Employees Retirement System who had been investing in Verisign Inc for a number of months, seems to be bullish on the $11.77B market cap company. The stock increased 3.61% or $4.2 during the last trading session, reaching $120.55. About 2.36M shares traded or 150.02% up from the average. VeriSign, Inc. (NASDAQ:VRSN) has risen 7.59% since February 18, 2017 and is uptrending. It has underperformed by 9.11% the S&P500.

Jim Tanenbaum increased its stake in Epizyme Inc. (EPZM) by 3.93% based on its latest 2017Q3 regulatory filing with the SEC. Foresite Capital Management Ii Llc bought 58,368 shares as the company’s stock rose 39.84% with the market. The hedge fund run by Jim Tanenbaum held 1.54 million shares of the health care company at the end of 2017Q3, valued at $29.40M, up from 1.48 million at the end of the previous reported quarter. Foresite Capital Management Ii Llc who had been investing in Epizyme Inc. for a number of months, seems to be bullish on the $1.26 billion market cap company. The stock decreased 2.68% or $0.5 during the last trading session, reaching $18.15. About 300,850 shares traded. Epizyme, Inc. (NASDAQ:EPZM) has risen 91.85% since February 18, 2017 and is uptrending. It has outperformed by 75.15% the S&P500.




Since August 24, 2017, it had 1 buying transaction, and 4 sales for $1.11 million activity. On Monday, September 25 the insider Ho Peter Tai-Ching sold $252,077. 72,264 shares were sold by Ros Matthew, worth $1.20 million on Monday, February 5.

Among 13 analysts covering Epizyme (NASDAQ:EPZM), 12 have Buy rating, 0 Sell and 1 Hold. Therefore 92% are positive. Epizyme had 31 analyst reports since August 6, 2015 according to SRatingsIntel. Jefferies initiated Epizyme, Inc. (NASDAQ:EPZM) on Wednesday, January 24 with “Buy” rating. On Thursday, November 2 the stock rating was maintained by Leerink Swann with “Buy”. The firm has “Buy” rating by Roth Capital given on Thursday, February 1. The rating was maintained by Oppenheimer with “Buy” on Wednesday, June 21. Mizuho maintained the shares of EPZM in report on Tuesday, May 10 with “Buy” rating. Oppenheimer maintained the stock with “Buy” rating in Monday, July 24 report. The firm has “Buy” rating given on Wednesday, June 14 by Oppenheimer. The stock has “Outperform” rating by RBC Capital Markets on Monday, September 28. As per Thursday, August 6, the company rating was maintained by Mizuho. As per Friday, August 4, the company rating was maintained by RBC Capital Markets.

Investors sentiment decreased to 1.46 in 2017 Q3. Its down 0.47, from 1.93 in 2017Q2. It dropped, as 15 investors sold EPZM shares while 22 reduced holdings. 13 funds opened positions while 41 raised stakes. 58.04 million shares or 22.28% more from 47.46 million shares in 2017Q2 were reported. Bain Public Equity Mgmt has invested 0.22% in Epizyme, Inc. (NASDAQ:EPZM). Northern owns 516,940 shares or 0% of their US portfolio. Jpmorgan Chase & Company owns 158,400 shares. Dekabank Deutsche Girozentrale accumulated 33,300 shares. Woodstock Corporation invested in 0.12% or 31,766 shares. Palo Alto Invsts Ltd Liability Corp holds 6.40 million shares or 5.13% of its portfolio. Baker Bros Advsr Limited Partnership holds 0.04% or 232,481 shares in its portfolio. Jacobs Levy Equity Incorporated holds 0% in Epizyme, Inc. (NASDAQ:EPZM) or 13,390 shares. Zurcher Kantonalbank (Zurich Cantonalbank) accumulated 0% or 988 shares. Alliancebernstein Limited Partnership invested 0% of its portfolio in Epizyme, Inc. (NASDAQ:EPZM). Nea Mgmt Company Llc stated it has 4.31% in Epizyme, Inc. (NASDAQ:EPZM). Deutsche Financial Bank Ag owns 289,701 shares. Foresite Cap Mngmt Ii Lc invested in 11.92% or 1.54 million shares. Principal Gp Inc holds 96,248 shares. Hanseatic Management Svcs accumulated 0% or 47 shares.

California Public Employees Retirement System, which manages about $67.30 billion US Long portfolio, decreased its stake in Arconic Inc by 26,600 shares to 887,533 shares, valued at $22.08 million in 2017Q3, according to the filing. It also reduced its holding in Senior Housing Prop Trust (NYSE:SNH) by 57,805 shares in the quarter, leaving it with 517,701 shares, and cut its stake in American Express Co (NYSE:AXP).

Investors sentiment decreased to 0 in 2017 Q3. Its down 0.09, from 0.09 in 2017Q2. It turned negative, as 35 investors sold VRSN shares while 3 reduced holdings. 0 funds opened positions while 0 raised stakes. 39.56 million shares or 15.68% less from 46.92 million shares in 2017Q2 were reported. 650,000 were reported by Commercial Bank Of New York Mellon. Financial Bank Of Nova Scotia holds 0.1% or 5.56 million shares in its portfolio. Penn has invested 0.05% in VeriSign, Inc. (NASDAQ:VRSN). State Street accumulated 0.01% or 33.15 million shares.

Among 6 analysts covering VeriSign (NASDAQ:VRSN), 1 have Buy rating, 2 Sell and 3 Hold. Therefore 17% are positive. VeriSign had 16 analyst reports since July 27, 2015 according to SRatingsIntel. The stock has “Hold” rating by Robert W. Baird on Friday, October 6. Robert W. Baird maintained the shares of VRSN in report on Thursday, October 26 with “Hold” rating. The firm has “Hold” rating by Cowen & Co given on Friday, October 2. Cowen & Co maintained VeriSign, Inc. (NASDAQ:VRSN) on Friday, October 27 with “Hold” rating. The firm has “Hold” rating by Robert W. Baird given on Thursday, August 31. The rating was maintained by Citigroup with “Neutral” on Friday, October 27. The firm has “Neutral” rating given on Wednesday, April 12 by Citigroup. The stock of VeriSign, Inc. (NASDAQ:VRSN) has “Hold” rating given on Friday, February 9 by Cowen & Co. As per Monday, July 27, the company rating was maintained by Topeka Capital Markets. As per Tuesday, January 5, the company rating was downgraded by Citigroup.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.